| Germline SDHB mutations and familial renal cell carcinoma C Ricketts, ER Woodward, P Killick, MR Morris, D Astuti, F Latif, ER Maher Journal of the National Cancer Institute 100 (17), 1260-1262, 2008 | 419 | 2008 |
| Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility D Astuti, MR Morris, WN Cooper, RHJ Staals, NC Wake, GA Fews, H Gill, ... Nature genetics 44 (3), 277-284, 2012 | 272 | 2012 |
| Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma MR Morris, CJ Ricketts, D Gentle, F McRonald, N Carli, H Khalili, M Brown, ... Oncogene 30 (12), 1390-1401, 2011 | 252 | 2011 |
| Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma MR Morris, C Ricketts, D Gentle, M Abdulrahman, N Clarke, M Brown, ... Oncogene 29 (14), 2104-2117, 2010 | 238 | 2010 |
| Mutations in SLC29A3, Encoding an Equilibrative Nucleoside Transporter ENT3, Cause a Familial Histiocytosis Syndrome (Faisalabad Histiocytosis) and Familial … NV Morgan, MR Morris, H Cangul, D Gleeson, A Straatman-Iwanowska, ... PLoS genetics 6 (2), e1000833, 2010 | 216 | 2010 |
| Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a … M Zatyka, NF da Silva, SC Clifford, MR Morris, MS Wiesener, KU Eckardt, ... Cancer research 62 (13), 3803-3811, 2002 | 189 | 2002 |
| Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma MR Morris, D Gentle, M Abdulrahman, EN Maina, K Gupta, RE Banks, ... Cancer research 65 (11), 4598-4606, 2005 | 147 | 2005 |
| DNA methylation profiles of long-and short-term glioblastoma survivors T Shinawi, VK Hill, D Krex, G Schackert, D Gentle, MR Morris, W Wei, ... Epigenetics 8 (2), 149-156, 2013 | 134 | 2013 |
| The epigenetic landscape of renal cancer MR Morris, F Latif Nature Reviews Nephrology 13 (1), 47-60, 2017 | 129 | 2017 |
| Bacillus subtilis natto: a non-toxic source of poly-γ-glutamic acid that could be used as a cryoprotectant for probiotic bacteria AR Bhat, VU Irorere, T Bartlett, D Hill, G Kedia, MR Morris, ... Amb Express 3, 1-9, 2013 | 125 | 2013 |
| Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma MR Morris, LB Hesson, KJ Wagner, NV Morgan, D Astuti, RD Lees, ... Oncogene 22 (43), 6794-6801, 2003 | 125 | 2003 |
| A comparative study of three-dimensional printing directions: The degradation and toxicological profile of a PLA/PHA blend JG Ausejo, J Rydz, M Musioł, W Sikorska, M Sobota, J Włodarczyk, ... Polymer degradation and stability 152, 191-207, 2018 | 120 | 2018 |
| Evidence for a telomere-independent “clock” limiting RAS oncogene-driven proliferation of human thyroid epithelial cells CJ Jones, D Kipling, M Morris, P Hepburn, J Skinner, A Bounacer, ... Molecular and cellular biology, 2000 | 110 | 2000 |
| The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain RP Pangeni, P Channathodiyil, DS Huen, LW Eagles, BK Johal, D Pasha, ... Clinical epigenetics 7, 1-17, 2015 | 107 | 2015 |
| Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma M Jafri, NC Wake, DB Ascher, DEV Pires, D Gentle, MR Morris, ... Cancer discovery 5 (7), 723-729, 2015 | 103 | 2015 |
| CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma FE McRonald, MR Morris, D Gentle, L Winchester, D Baban, J Ragoussis, ... Molecular cancer 8, 1-11, 2009 | 95 | 2009 |
| Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma MR Morris, D Gentle, M Abdulrahman, N Clarke, M Brown, T Kishida, ... British journal of cancer 98 (2), 496-501, 2008 | 86 | 2008 |
| Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma MR Morris, E Maina, NV Morgan, D Gentle, D Astuti, H Moch, T Kishida, ... Journal of clinical pathology 57 (7), 706-711, 2004 | 84 | 2004 |
| The relative DNA-shedding propensity of the palm and finger surfaces AA Oleiwi, MR Morris, WM Schmerer, R Sutton Science & Justice 55 (5), 329-334, 2015 | 82 | 2015 |
| Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma CJ Ricketts, MR Morris, D Gentle, S Shuib, M Brown, N Clarke, W Wei, ... Clinical epigenetics 5, 1-14, 2013 | 82 | 2013 |
Eamonn MaherAston UniversityVerified email at aston.ac.uk
